Cargando…
IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand
BACKGROUND: Bone is one of the major target tissues for Insulin-like Growth Factor I (IGF-I). Low doses of IGF-I were able to improve liver-associated osteopenia. In the present work, a model of partial IGF-I deficiency was used in order to provide insight into the mechanisms of the beneficial actio...
Autores principales: | Guerra-Menéndez, Lucia, Sádaba, Maria C, Puche, Juan E, Lavandera, Jose L, de Castro, Luis F, de Gortázar, Arancha R, Castilla-Cortázar, Inma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231608/ https://www.ncbi.nlm.nih.gov/pubmed/24161214 http://dx.doi.org/10.1186/1479-5876-11-271 |
Ejemplares similares
-
Liver mitochondrial dysfunction is reverted by insulin-like growth factor II (IGF-II) in aging rats
por: Garcia-Fernandez, Maria, et al.
Publicado: (2011) -
Human conditions of insulin-like growth factor-I (IGF-I) deficiency
por: Puche, Juan E, et al.
Publicado: (2012) -
Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption
por: Cawley, Keisha M., et al.
Publicado: (2020) -
Hepatoprotection and neuroprotection induced by low doses of IGF-II in aging rats
por: Castilla-Cortázar, Inma, et al.
Publicado: (2011) -
Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003)